Enclosure:
|
Partner Communications Reports that its Controlling Shareholder Filed an Immediate Report
|
Mr. Ziv Leitman
Chief Financial Officer
Tel: +972-54-7814951
E-mail: investors@orange.co.il
|
Ms. Yaffa Cohen-Ifrah
Head of Investor Relations
Tel: +972 54 909 9039
E-mail: Yaffa.cohenifrah@orange.co.il
|
To
Israel Securities Authority
22 Kanfei Nesharim St.
Jerusalem 95464
(Via Magna)
|
To
Tel-Aviv Stock Exchange
54 Ahad Ha'am St.
Tel-Aviv 65202
(Via Magna)
|
1.
|
The Transaction
|
|
1.1
|
The Company shall sell and transfer to the Buyer 47,833,333 Partner Shares (“the Shares Being Purchased”), which constitute, as of the date of this report, approximately 30.73% of Partner’s Share Capital. This being in consideration of the assignment of the Advent Loan (as this term is described hereunder) to the Buyer on the Consummation Date (as this term is described hereunder), as well as a payment in cash at the sum of NIS 250 (two hundred and fifty) million, which shall be paid by the Buyer on the Consummation Date (“the Consideration in Cash”). Pursuant to the Agreement, Scailex retains the right to receive the dividends in respect of the Shares Being Purchased on the Consummation Date (“the Share of the Dividend”) at the sum of up to approximately NIS 115 million, pursuant to the conditions prescribed in the Purchase Agreement. The Share of the Dividend reflects a dividend per share at the sum of NIS 2.56994, in respect of each of the Shares Being Purchased on the Consummation Date (as these terms are defined hereunder), this being in respect of dividends that Partner shall distribute at the height of Partner’s distributable profits as of December 31, 2012 (“the Sum of the Share of the Dividend”). The Sum of the Share of the Dividend shall be reduced proportionately (directly proportionate), insofar as Partner’s total distributable profits as of to December 31, 2012 shall be less than NIS 400 million.
|
|
1.2
|
On the Consummation Date, which is to occur no later than three business days after the fulfillment of all of the relevant suspending conditions (“the Consummation Date”):
|
|
a.
|
The Buyer shall assume the Company’s entire debt at the sum of 300 million U.S. Dollars (“USD”), which was provided to the Company by Advent Investment Pte. Ltd. (“Advent”), a Singapore corporation controlled by the Hutchison Group (“the Advent Loan”), and in respect whereof the Company issued the Company’s Series E Notes1 to Advent (“Assignment of the Advent Loan”), and, accordingly, the Company shall be fully released from any indebtedness in respect of the Advent Loan. The Company undertook to assume and to pay all of the applicable interest by virtue of the Advent Loan up until the Consummation Date.
|
|
b.
|
The Company shall sell and transfer 44,850,000 Partner Shares to the Buyer (“the Shares Being Purchased on the Consummation Date”), which constitute, as of the date of this report, approximately 28.82% of Partner’s Share Capital.
|
|
c.
|
The Company shall receive the sum of the Consideration in Cash.
|
|
1.3
|
On the date of the Deferred Consummation Date (as this term is defined hereunder), the Company shall sell and transfer to the Buyer up to 2,983,333 additional Partner Shares (all or a portion thereof, according to the mechanism described hereunder), which constitute, as of the date of this report, approximately 1.92% of Partner’s Share Capital (“the Additional Shares”).2
|
|
1.4
|
If Bank Leumi le-Israel Ltd. (“BLL”) shall seek to realize shares of Partner that it possesses, in respect of a tag-along right that Bank Leumi has vis-à-vis the Company, which could arise as a result of the execution of this Agreement, then the Buyer shall purchase from BLL up to 3,166,677 Partner Shares. Insofar as BLL shall seek to realize additional shares of Partner, then the Company and the Buyer shall severally purchase 50% of such quantity of shares, provided that: (a) the conditions of purchase from Bank Leumi shall be agreed upon by the Company and the Buyer; (b) in no instance shall the Buyer and the Company be required to purchase from Bank Leumi more than 5.3 million shares of Partner.
|
1
|
These notes are traded on the Tel-Aviv Stock Exchange Ltd. via TACT – Institutional (Tel-Aviv continuous institutional trading).
|
2
|
The quantity of Shares Being Purchased is equal to the Shares Being Purchased on the Consummation Date plus the Additional Shares.
|
|
1.5
|
Each party shall assume any tax or expense applicable thereto as a consequence of the execution of the Transaction. Any consideration that shall be transferred to the Company in the Transaction (including assignment of the Advent Loan) shall be subject to withholding tax, insofar as the Company shall not issue an appropriate tax exemption to the Buyer.
|
|
1.6
|
As of the date of this report, the Company holds 69,325,594 Partner Shares, which constitute approximately 44.54% of Partner’s Share Capital. Out of this total of Partner Shares above: (a) 24,380,739 Partner Shares, which constitute approximately 15.7% of Partner’s Share Capital, are pledged in favor of the trustees for the holders of the Company’s notes (Series A through D and F) (“the Secured Public Notes”); (b) 19,056,720 Partner Shares, which constitute approximately 12.2% of Partner’s Share Capital, are pledged in favor of the trustee for the Advent Loan (as this term is defined below), against which the Company issued the Company’s Series E Notes as stated (“Advent’s Pledged Shares”); and (c) 25,888,134 Partner Shares, which constitute approximately 16.6% of Partner’s Share Capital, are free and clear of any lien as stated (“Unencumbered Shares”).4
|
|
1.7
|
The Shares Being Purchased include Advent’s Pledged Shares, the Unencumbered Shares and additional Partner Shares that are free and clear of any lien, which shall constitute approximately 1.92% of Partner’s Share Capital, which the Company shall hold due to purchases that it shall transact on the market and/or as a result of removal of a lien in favor of the holders of the Secured Public Notes as a result of buy-backs of these notes. In any event, apart from Advent’s Pledged Shares (which shall be transferred along with the existing lien on them in favor of Advent), the Shares Being Purchased shall be transferred by the Company to the Buyer being free and clear of any lien.
|
|
1.8
|
Subsequent to the completion of the operations specified above in clause 1, and assuming that the Buyer shall not purchase shares of Partner from BLL as specified above in clause 1.4, on the Consummation Date: the Company and the Buyer are expected to each hold approximately 15.73% and approximately 28.82% of Partner’s Share Capital, respectively; Suny Electronics Ltd. (“Suny”), the controlling shareholder of the Company, which is not a party to the Transaction, shall hold 1.4% of Partner’s Share Capital,5 while the public shall hold the balance of the holdings. Subsequent and subject to the Deferred Consummation Date, on the Consummation Date: the Company and the Buyer are expected to each hold approximately 13.81% and approximately 30.73% of Partner’s Share Capital, respectively; Suny shall hold 1.4% of Partner’s Share Capital,6 while the public shall hold the balance of the holdings. On the Consummation Date, the Company, the Buyer and Suny shall aggregately hold approximately 45.94% of Partner’s Share Capital.
|
|
1.9
|
As of the Consummation Date, the Company and the Buyer intend to act in collaboration, pursuant to the provisions of a shareholders’ agreement that is to be signed between them with respect to their rights in the company and to their relations as controlling shareholders of Partner, the principal provisions of which are described hereunder in clause 8.
|
4
|
Suny Electronics Ltd., the controlling shareholder of the Company, holds 1.4% of Partner’s Share Capital; however, it is not a party to the Transaction.
|
2.
|
Representations
|
3.
|
Undertakings during the interim period
|
4.
|
Suspending Conditions
|
5.
|
Indemnification
|
6.
|
Cancellation of the Agreement
|
7.
|
Assignment of the Advent Loan
|
|
7.1
|
Concurrent with the signing of the Purchase Agreement, the Buyer and Advent (including an additional party in the Hutchison Group) engaged in an assignment agreement that regulates the relations between the Buyer and Advent in relation to all matters pertaining to the assignment of the Advent Loan (“the Assignment Agreement”). The consummation of the Assignment Agreement and the consummation of the Purchase Agreement are interdependent and shall be executed simultaneously.
|
|
7.2
|
The Company and Advent agreed to sign a reciprocal waiver and release document on the Consummation Date, under which it was agreed that, subject to the consummation of the Purchase Agreement and the Assignment Agreement, and in effect as of the Consummation Date as stated, including the execution of the assignment of the Advent Loan (including the payment of the interest in respect of the Advent Loan that is applicable up until the Consummation Date), the Company and Advent shall each irrevocably and unconditionally waive towards each other and any party on its behalf, any claim and/or allegation that might exist between them in relation to the Advent Loan (“the Reciprocal Waiver”). The Reciprocal Waiver shall be void ab initio in the event that the Assignment Agreement and/or the Purchase Agreement shall be cancelled or shall become invalid as a result of a judicial proceeding. In such instance, all of the rights and obligations between the Company and Advent pursuant to the Advent Loan shall revert to their original validity, all of the rights pursuant to the Assignment Agreement shall be rescinded, and each of the parties to the Assignment Agreement, as well as Scailex, shall be entitled to their rights and assets as had existed prior to the Consummation Date.
|
|
7.3
|
On the Signing Date, the Company also signed the following undertakings vis-à-vis Advent, which shall come into effect on the Consummation Date:
|
|
a.
|
The Company approves the engagement in the Assignment Agreement and the consummation thereof.
|
|
b.
|
The Company shall not assume any financial liability that is not during the ordinary course of business until the earlier of: (1) one business day after the Consummation Date; (2) 10 business days after the Assignment Agreement has been duly cancelled;
|
|
c.
|
To summon general meetings of holders of the Company’s public notes (Series A through D, F through I and Series 1), during which the noteholders shall be asked to approve the engagement in the Purchase Agreement and the assignment of the Advent Loan, which shall be convened by no later than December 25, 2012.
|
|
d.
|
Insofar as the consent of the holders of the public notes shall not be received prior to December 25, 2012, and if proceedings shall be instituted against Scailex, including liquidation or settlement proceedings, or if they threatened to institute such proceedings immediately, then Scailex shall cooperate with the Buyer and Advent in relation to the filing of a motion to the court to approve the Assignment Agreement or an arrangement similar thereto by way of an arrangement.
|
8.
|
Shareholders’ agreement between the Company and the Buyer
|
|
8.1
|
Subject to the provisions of any law, the Company and the Buyer agreed to a preliminary meeting to coordinate a uniform vote in advance of Partner’s general meeting. This arrangement shall apply as long as the Buyer and its related bodies have more Partner Shares than the Company, related bodies of the Company and a third party have, if the Company shall sell shares of Partner pursuant to the provisions of the Shareholders’ Agreement, and which shall join the Shareholders’ Agreement (“Joining Third Party”). This arrangement shall be decided by a simple majority of all of the voting rights in Partner of the Company, the Buyer, their related bodies and their Joining Third Parties. This arrangement shall apply, inter alia, to the matter of appointment of directors to Partner’s Board of Directors, as agreed upon between the parties as specified hereunder in clause 8.3; to the execution of particular amendments to Partner’s Articles of Association; to the approval of management agreements between the Buyer and/or its related bodies and Partner; to the approval of a registration rights agreement between the Company, the Buyer and Partner, whereby the Company and the Buyer shall be entitled to demand particular rights from Partner in relation to the listing of Partner shares for trading on the NASDAQ; to the approval of run-off insurance for incumbent officers of Partner prior to the Consummation Date; to the approval of a release, indemnity and insurance for officers who shall be holding office subsequent to the Consummation Date.
|
|
8.2
|
Notwithstanding that stated above in clause 8.1, and subject to the provisions of any law, it was agreed that as long as Scailex and its related bodies cumulatively hold at least 10% of Partner’s Share Capital, the Buyer and its related bodies shall not be allowed to approve any of the following actions during Partner’s general meeting without having received Scailex’s written consent thereto: (a) a material change in Partner’s sphere of business, or entry into a material new sphere of business; (b) a merger of Partner with a communications service-provider, or the acquisition thereof by Partner in a transaction valued in excess of USD 250 million; (c) the opening of liquidation or dissolution proceedings, or a stay of proceedings or a creditors’ arrangement; (d) transactions with interested parties, apart from the management agreements, a purchase of shares within the scope of a rights offering in Partner, a distribution of dividends or a rights registration agreement; (e) a change in Partner’s Share Capital that has a material and disproportionate adverse impact on Scailex’s rights to Partner Shares, or an allotment of a class of shares (or similar security) having preference over Partner Shares; (f) delisting of Partner shares from the Tel-Aviv Stock Exchange Ltd.; (g) amendments to Partner’s Articles of Association that have a material and disproportionate adverse impact on Scailex’s rights by virtue of the Articles of Association.
|
|
8.3
|
Subject to the provisions of any law, the Company and the Buyer agreed to institute all operations that are required, including the exercise of their voting power during Partner’s general meeting, in order to ensure that the composition of Partner’s Board of Directors shall be as follows: (a) the majority of the members of the Board of Directors shall be candidates who have been recommended by the Buyer; (b) the number of members of the Board of Directors who shall be candidates who are recommended by Scailex shall be determined according to the cumulative ratio of holdings of Partner’s Share Capital by Scailex and its related bodies, as follows: two members, if the cumulative holding ratio of Partner’s Share Capital is at least 10%; one member – if the cumulative holding ratio of Partner’s Share Capital is at least 5% but not more than 10% of Partner’s Share Capital; (c) that stated above in subclauses (a) and (b) shall not derogate from Scailex’s right, insofar as it shall exist, to be involved in the appointment of an “Israeli director” of Partner by Partner shareholders that are classified as “Israeli parties”; (d) as long as Scailex is entitled to appoint at least one director recommended on its behalf as stated, subject to any law, one director on its behalf shall be appointed as a member of each of the committees of Partner’s Board of Directors. The provisions of this clause shall be rescinded on the date that Scailex and its related bodies shall be owners of more Partner Shares than the Buyer and its related bodies own.
|
|
8.4
|
Subject to the provisions of any law, the Company vested the Buyer a Right of First Offer, in the instance whereby the Company and/or its related bodies shall seek to transfer at least 5% of Partner’s Share Capital to a third party (“the Offered Shares”), and, if the Right of First Offer was not exercised, the Right to Match, relative to the Offered Shares in the event that an offer from a third party shall be accepted in respect thereof; all being in accordance with and subject to the conditions and circumstances prescribed in the Shareholders’ Agreement. It is hereby clarified that the above Right of First Offer and Right to Match shall not apply in relation to the following: (a) a distribution of Partner Shares on the open market; (b) a sale of Partner Shares on the open market; (c) a transfer of shares to a related body of Scailex, which is controlled by Scailex (and which shall join Scailex as a party to the agreement); (d) a pledge of shares of Partner in relation to the assumption of a debt and/or in relation to a guarantee given in favor of related bodies of Scailex; (e) any sale to a third party by Scailex or any of its related bodies of less than 5% of Partner’s Share Capital.
|
|
8.5
|
Subject to the provisions of any law, the Shareholders’ Agreement shall automatically be cancelled or may be cancelled, as the case may be, in the following instances: (a) in the event of a change in control or insolvency or entry into an insolvency proceeding of Scailex – the Buyer shall be entitled to cancel; (b) in the event of a change in control over the Buyer or insolvency or entry into an insolvency proceeding of the Buyer – Scailex shall be entitled, for reasonable reasons, to cancel; (c) automatically, in the event that Scailex and its related bodies or the Buyer and its related bodies shall cumulatively hold less than 5% of Partner’s Share Capital; and (d) by Scailex or by the Buyer, and for any reason, in the event that Scailex and its related bodies shall be owners of more Partner shares than the Buyer and its related bodies own.
|
9.
|
Accounting, tax and cash flow implications
|
Sincerely,
Scailex Corporation Ltd.
by: Mr. Yahel Shachar, C.E.O.
|
Partner Communications Company Ltd.
|
|||
|
By:
|
/s/ Ziv Leitman | |
Name: Ziv Leitman | |||
Title: Chief Financial Officer | |||